Around 85% of primary lung cancers are non-small cell lung cancer (NSCLC).[1] Numerous oncogenic drivers, including mutations in the genes encoding the epidermal growth factor receptor (EGFR), have been recognized in NSCLC. This evidence concerns the gene EGFR and lung carcinoma.